Answers are grounded in this paper and cite their sources.
Intracellular calcium from endoplasmic reticulum (ER) stores is used in regulation of bone. Calcium is sequestered in the ER by ATP2A2 Ca 2+ ATPase; initial Ca 2+ release is by phospholipase C-coupled plasma membrane receptors producing inositol (1,4,5) trisphosphate (ITP3) for ITP3 receptors on the ER releasing Ca 2+ , with steady state supporting high ER calcium. Additional channels release ER calcium, called Store Operated Ca 2+ Entry (SOCE). This occurs in bone-forming osteoblasts, from stromal stem cells, and in bone-degrading osteoclasts, from monocytic precursors. Major SOCE mediators are Orai1 plasma-membrane Ca 2+ channels interacting with STIM regulatory proteins in the ER, and plasma-membrane TRP (transient receptor potential) channels. SOCE is well studied in bone but occurs widely; it reflects early evolutionary development and occurs in tissues including muscle, liver, kidney and lymphocytes. We discuss briefly other Ca 2+ regulators in relationship to SOCE, including ITPR, Mitochondria, TRPV1, Piezo, and TRPM7. Macrophages and osteoclasts express STIM1 at high levels. STIM1 activates Orai1. When Ca 2+ in the ER drops, ER-bound STIM1 binds Orai1 in the cell membrane. Both osteoblast and osteoclast formation require Orai1. Osteoblast-osteoclast interaction is, in part, dependent on Ca 2+ signaling. TRPC channels also modify intracellular calcium during differentiation of bone cells. TRPCs, including TRPC1 and 4, are expressed in osteoblasts and osteoclasts. Novel small-molecule inhibitors targeting TRPC channels may inhibit bone degradation with minimal effects on other organs. Overall, a complex web of Ca 2+ -dependent growth and differentiation factors is important in the differentiation and regulation of bone-forming and bone-degrading cells.
No takes yet. Share an insight, caveat, or question.
Blair et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: